Azenta (NASDAQ:AZTA) Rating Lowered to “Hold” at Wall Street Zen

by · The Cerbat Gem

Azenta (NASDAQ:AZTA – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Sunday, Wall Street Zen reports.

Several other equities research analysts have also recently issued reports on the company. Weiss Ratings raised Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 26th. Needham & Company LLC reissued a “buy” rating and issued a $37.00 price objective on shares of Azenta in a research note on Monday, September 14th. Four investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $41.20.

Check Out Our Latest Stock Report on AZTA

Azenta Price Performance

AZTA opened at $34.84 on Friday. The firm has a market cap of $1.53 billion, a P/E ratio of -12.62 and a beta of 1.52. The company has a 50 day simple moving average of $34.21 and a two-hundred day simple moving average of $27.59. Azenta has a 1-year low of $15.93 and a 1-year high of $46.41.

Azenta (NASDAQ:AZTA – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. Azenta had a positive return on equity of 1.18% and a negative net margin of 20.63%. The business had revenue of $161.18 million during the quarter, compared to analyst estimates of $149.31 million.

Institutional Investors Weigh In On Azenta

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Assenagon Asset Management S.A. purchased a new position in shares of Azenta during the third quarter valued at $3,475,000. Legacy Wealth Asset Management LLC bought a new stake in shares of Azenta in the third quarter valued at about $246,000. GAMMA Investing LLC lifted its stake in Azenta by 43.8% in the third quarter. GAMMA Investing LLC now owns 4,454 shares of the company’s stock worth $155,000 after acquiring an additional 1,357 shares during the period. Green Alpha Advisors LLC lifted its stake in Azenta by 3.5% in the third quarter. Green Alpha Advisors LLC now owns 9,187 shares of the company’s stock worth $321,000 after acquiring an additional 313 shares during the period. Finally, Integrated Wealth Concepts LLC purchased a new stake in Azenta in the second quarter worth about $39,000. 99.08% of the stock is owned by institutional investors.

Azenta Company Profile

(Get Free Report)

Azenta, Inc (NASDAQ: AZTA) is a life sciences company that provides products and services for the management, storage, and analysis of biological and chemical samples. Its offerings support pharmaceutical and biotechnology companies, academic and government research institutions, clinical research organizations, and other laboratories.

The company’s products include automated sample storage systems, laboratory automation equipment, sample-management software, consumables, and cold-storage solutions designed to preserve and track biological materials.

Featured Articles